The Challenge of Studying Long COVID: An Updated Review
- PMID: 35213866
- PMCID: PMC8997013
- DOI: 10.1097/INF.0000000000003502
The Challenge of Studying Long COVID: An Updated Review
Abstract
Accurately determining the risk of long COVID is challenging. Existing studies in children and adolescents have considerable limitations and distinguishing long-term SARS-CoV-2 infection-associated symptoms from pandemic-related symptoms is difficult. Over half of individuals in this age group, irrespective of COVID-19, report physical and psychologic symptoms, highlighting the impact of the pandemic. More robust data is needed to inform policy decisions.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
Figures
Comment in
-
Balancing the medical and social needs of children during the COVID-19 pandemic.Med J Aust. 2023 Feb 20;218(3):140. doi: 10.5694/mja2.51808. Epub 2022 Dec 5. Med J Aust. 2023. PMID: 36471917 Free PMC article. No abstract available.
References
-
- Zimmermann P, Pittet LF, Curtis N. Long covid in children and adolescents. BMJ. 2022;376:o143. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous